1. Home
  2. KBH vs XENE Comparison

KBH vs XENE Comparison

Compare KBH & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$51.96

Market Cap

3.8B

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$59.21

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
XENE
Founded
1957
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
KBH
XENE
Price
$51.96
$59.21
Analyst Decision
Hold
Strong Buy
Analyst Count
14
12
Target Price
$56.17
$67.17
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
03-24-2026
05-11-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
N/A
EPS
0.52
N/A
Revenue
$4,547,002,000.00
$311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.60
$2,436.26
P/E Ratio
$99.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$48.17
$28.19
52 Week High
$68.71
$62.91

Technical Indicators

Market Signals
Indicator
KBH
XENE
Relative Strength Index (RSI) 44.65 67.24
Support Level $48.89 $39.93
Resistance Level $66.32 $59.44
Average True Range (ATR) 1.68 1.92
MACD 0.43 -0.12
Stochastic Oscillator 69.98 88.93

Price Performance

Historical Comparison
KBH
XENE

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: